Skip to main content
Terug
TEM logo

Tempus AI, Inc.

Datakwaliteit: 100%
TEM
NASDAQ Healthcare Medical - Healthcare Information Services
€ 46,76
▼ € 2,07 (-4,24%)
Marktkapitalisatie: 8,12B
Dagbereik
€ 46,33 € 50,75
52-Weeksbereik
€ 36,22 € 104,32
Volume
4.756.862
50D / 200D Gem.
€ 57,60 / € 69,23
Vorige Slotkoers
€ 48,83

Quick Summary

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (631 peers)

Metriek Aandeel Sector Mediaan
P/E -33,2 0,3
P/B 16,5 3,0
ROE % -89,5 3,7
Net Margin % -19,3 3,8
Rev Growth 5Y % 49,0 10,0
D/E 1,7 0,2

Koersdoel Analisten

Hold
€ 87,11 +86.3%
Low: € 59,00 High: € 105,00
Forward WPA
-€ 0,40
Omzet Sch.
1,59B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 3,05
€ 2,93 – € 3,21
 3,18B 2
FY2029 € 1,87
€ 1,80 – € 1,97
 2,70B 4
FY2028 € 0,76
-€ 0,56 – € 1,98
 2,31B 6

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-24 -€ 0,04 -€ 0,04 +8,8%
2025-11-04 -€ 0,17 -€ 0,11 +36,2%
2025-08-08 -€ 0,23 -€ 0,22 +4,3%
2025-05-06 -€ 0,26 -€ 0,24 +7,7%
2025-02-24 -€ 0,15 -€ 0,18 -20,0%
2024-11-04 -€ 0,27 -€ 0,25 +6,0%
2024-08-06 -€ 0,59 -€ 0,63 -6,8%
2024-06-17 N/A -€ 0,38 —

Dividend History

Yield

0,00%

Payout Ratio

0,00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Belangrijkste Punten

Revenue grew 49,03% annually over 5 years — strong growth
Negative free cash flow of -239,14M
PEG of 0,61 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 34,38%
Capital efficient — spends only 1,66% of revenue on capex

Groei

Revenue Growth (5Y)
49,03%
Revenue (1Y)83,41%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-89,48%
ROIC-13,69%
Net Margin-19,27%
Op. Margin-18,76%

Veiligheid

Debt / Equity
1,66
Current Ratio3,13
Interest Coverage-3,40

Waardering

P/E Ratio
-33,15
Forward P/EN/A
P/B Ratio16,53
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 83,41% Revenue Growth (3Y) 54,64%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 49,03% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,27B Net Income (TTM) -245,03M
ROE -89,48% ROA -10,77%
Gross Margin 69,64% Operating Margin -18,76%
Net Margin -19,27% Free Cash Flow (TTM) -239,14M
ROIC -13,69% FCF Growth (3Y) N/A
Safety
Debt / Equity 1,66 Current Ratio 3,13
Interest Coverage -3,40
Dividends
Dividend Yield 0,00% Payout Ratio 0,00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -33,15 Forward P/E N/A
P/B Ratio 16,53 P/S Ratio 6,39
PEG Ratio 0,61 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 5,10 Fwd Earnings Yield N/A
FCF Yield -2,94%
Market Cap 8,12B Enterprise Value 8,33B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,27B 693,40M 531,82M 320,67M 257,85M
Net Income -245,03M -705,81M -214,12M -289,81M -259,19M
EPS (Diluted) -1,41 -4,60 -1,73 -1,97 -1,75
Gross Profit 885,69M 381,11M 286,18M 130,19M 83,64M
Operating Income -238,64M -691,08M -196,08M -265,44M -243,71M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,27B 926,12M 564,05M 631,36M 531,35M
Total Liabilities 1,78B 869,78M 1,95B 1,76B 1,34B
Shareholders' Equity 491,33M 56,34M -1,38B -1,13B -807,49M
Total Debt 815,71M 468,09M 488,14M 433,03M 238,95M
Cash & Equivalents 604,79M 340,95M 165,77M 302,94M 277,69M
Current Assets 1,17B 667,60M 350,33M 438,63M 403,99M
Current Liabilities 372,39M 291,07M 232,63M 174,24M 114,81M

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Full Throttle
#3 of 146
82

Recente Activiteit

Ingestapt Full Throttle
Mar 24, 2026